| Ability Rehab Services, Llc | |
|
611 New York Ave, Absecon, NJ 08201-1627 | |
| (609) 204-5289 | |
| Not Available |
| Full Name | Ability Rehab Services, Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Gerontology |
| Location | 611 New York Ave, Absecon, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215490404 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XG0600X | Occupational Therapist - Gerontology | (* (Not Available)) | Primary |
| Provider Name | Donna M Hartey |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1497769525 PECOS PAC ID: 2769465236 Enrollment ID: I20040608000393 |
News Archive
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
"Measles has killed 126 children in Yemen since mid-2011, a consequence of the breakdown of basic health services during the year-long political crisis," and "in response ... , the Yemeni government has appealed for international assistance and an outbreak-response vaccination campaign will begin in the hardest-hit regions on 10 March," IRIN reports.
Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF).
Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
› Verified 1 days ago
| Provider Name | Shannon L Whaley |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1811238231 PECOS PAC ID: 9537305818 Enrollment ID: I20130410000398 |
News Archive
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
"Measles has killed 126 children in Yemen since mid-2011, a consequence of the breakdown of basic health services during the year-long political crisis," and "in response ... , the Yemeni government has appealed for international assistance and an outbreak-response vaccination campaign will begin in the hardest-hit regions on 10 March," IRIN reports.
Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF).
Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
› Verified 1 days ago
| Provider Name | Lisa Susan Lockard |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1992975858 PECOS PAC ID: 4587098447 Enrollment ID: I20191231000799 |
News Archive
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
"Measles has killed 126 children in Yemen since mid-2011, a consequence of the breakdown of basic health services during the year-long political crisis," and "in response ... , the Yemeni government has appealed for international assistance and an outbreak-response vaccination campaign will begin in the hardest-hit regions on 10 March," IRIN reports.
Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF).
Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
› Verified 1 days ago
| Provider Name | Jennifer Martino |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1194849786 PECOS PAC ID: 1254754203 Enrollment ID: I20200708003766 |
News Archive
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
"Measles has killed 126 children in Yemen since mid-2011, a consequence of the breakdown of basic health services during the year-long political crisis," and "in response ... , the Yemeni government has appealed for international assistance and an outbreak-response vaccination campaign will begin in the hardest-hit regions on 10 March," IRIN reports.
Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF).
Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ability Rehab Services, Llc 611 New York Ave, Absecon, NJ 08201-1627 Ph: (609) 204-5289 | Ability Rehab Services, Llc 611 New York Ave, Absecon, NJ 08201-1627 Ph: (609) 204-5289 |
News Archive
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
"Measles has killed 126 children in Yemen since mid-2011, a consequence of the breakdown of basic health services during the year-long political crisis," and "in response ... , the Yemeni government has appealed for international assistance and an outbreak-response vaccination campaign will begin in the hardest-hit regions on 10 March," IRIN reports.
Memory loss, cognitive impairment, brain cell degeneration and cell death were prevented or reversed in several animal models after treatment with a naturally occurring protein called brain-derived neurotrophic factor (BDNF).
Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
› Verified 1 days ago
Lisa Amaquandoh, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 117 Mohawk Ln, Absecon, NJ 08201 Phone: 609-277-5085 | |
Maggie Ann Seel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 Pitney Rd, Absecon, NJ 08201 Phone: 609-646-5400 | |
Christopher Guishard I, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 Pitney Rd, Absecon, NJ 08201 Phone: 609-646-5400 | |
Lisa Susan Lockard, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 611 New York Ave, Absecon, NJ 08201 Phone: 609-646-1368 Fax: 609-646-1368 |